Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories Limited entered the US in the year 1994 and started marketing generic products that were ANDA approved. Within a quick span of time it emerged as the largest pharmeceutical market in the United States of America as it accounted for 28 percent of the Ranbaxy’s sales in the year 2005. This success of Ranbaxy continued for twelve months, as at the end of the year that is on 31st December in the year 2005 the company’s global sales were US.$1,178 million with the overseas market accounting for 75 percent of global sales that is to be specific, USA accounted for 28 percent, Europe accounted for 17 percent and Brazil, China and Russia accounted for 29 percent.
Another milestone was achieved by the Ranbaxy in the year 2006 on the 23rd of June, for the reason that it received from the US Food and Drug Administration (a 180-day exclusivity to sell srimvastin, a hypolipidemic drug as a generic drug in the United States of America).
In the year 2006, this company achieved sales of US $379. Given below is the address of the Ranbaxy Laboratories Limited situated in US, which is:
Ranbaxy Inc.
600 College Road East
Suite 2100
Princeton
NJ 08540
US
usforindians offers the necessary information on Ranbaxy. |
